HEDIS Perinatal Depression Screening for Pennsylvania Health Plans
#TLDR
PPC tracks first-trimester prenatal care and a postpartum visit 7-84 days after delivery. (NCQA – PPC)
PND-E and PDS-E measure prenatal/postpartum depression screening with a standardized instrument plus follow-up within 30 days of a positive screen. (NCQA – PDS-E; Policy Center for Maternal Mental Health)
MY2023 national averages: Medicaid prenatal screening 13.2%, postpartum 8.7%; commercial 5.1% and 4.4%. Pennsylvania Medicaid led at 24.6% / 24.1%, still most deliveries outside the numerator. (Policy Center / Quality Compass MY2023)
ACOG recommends standardized screening for depression and anxiety at the initial prenatal visit, later in pregnancy, and postpartum, with systems for diagnosis and follow-up. (ACOG CPG No. 4)
For PA plans: the bottleneck is coded screens + same-window follow-up + postpartum visit completion between OB visits. Phia is a licensed PA perinatal medical group for continuous screening, same-day clinical response, and claims-visible encounters. Partner with Phia · PA Medicaid postpartum coverage
Who this is for
Quality, population health, and maternity leaders at Pennsylvania Medicaid MCOs and commercial plans, plus OB leaders who own HEDIS denominators. Patient-facing guides: PPD symptoms, postpartum anxiety, PPD test.
The three HEDIS measures
1. PPC: Prenatal and Postpartum Care
Rate | Definition |
|---|---|
Timeliness of Prenatal Care | Prenatal visit in the first trimester, or on/before enrollment start, or within 42 days of enrollment |
Postpartum Care | Postpartum visit on or between 7 and 84 days after delivery |
NCQA frames PPC as routine outpatient prenatal and postpartum care, not emergency treatment. More than half of maternal deaths occur after birth. Pennsylvania’s 12-month Medicaid postpartum coverage extends the benefit year, but HEDIS PPC still keys off the early postpartum window. (KFF; Phia PA Medicaid guide)
2. PND-E: Prenatal Depression Screening and Follow-Up
ECDS measure with two rates: (1) documented result from an age-appropriate standardized instrument during pregnancy; (2) among positives, follow-up on or up to 30 days after the first positive screen via defined visits, BH encounters, case management with assessment, certain counseling codes, antidepressant dispense, or same-day full-length negative screen after a brief positive. (Policy Center specs)
3. PDS-E: Postpartum Depression Screening and Follow-Up
Screening with a standardized instrument in the postpartum period; follow-up within 30 days of a positive finding. Spec detail often places screening in the 7-84 day window after delivery, same operational sprint as PPC. (NCQA – PDS-E; Policy Center)
NCQA notes perinatal depression roughly 12%–15%, postpartum depression alone as high as 20% in some U.S. regions, and cites cost-effectiveness of screening and treatment (~$1,000 per woman vs ~$10,200 savings per remission in one analysis). (NCQA – PDS-E)
National and Pennsylvania benchmarks (MY2023)
Population | PND-E (prenatal) | PDS-E (postpartum) |
|---|---|---|
U.S. Medicaid | 13.2% | 8.7% |
U.S. commercial | 5.1% | 4.4% |
PA Medicaid | 24.6% (highest state) | 24.1% (highest state) |
PA commercial | 8.0% | 10.7% |
(Policy Center analysis of Quality Compass MY2023)
Follow-up after positive screens (national 2023): prenatal ~50.4% Medicaid / 58.5% commercial; postpartum ~62.1% Medicaid / 66.3% commercial. About 73% of Medicaid and 92-93% of commercial HEDIS reporters submitted PND-E/PDS-E even while voluntary. PA leads and still leaves roughly three in four deliveries outside the reported numerator. (Policy Center)
Why rates under-count clinical activity
LOINC / ECDS: measures need electronic documentation of the specific instrument. Paper or free-text “mood OK” often never enters the numerator.
Voluntary reporting: weaker data pipelines can artificially suppress rates.
PA is among states that require MCO reporting of these measures and that provide separate Medicaid reimbursement for MMH screening. (Policy Center)
ACOG clinical standard vs HEDIS
Domain | ACOG direction | HEDIS can count |
|---|---|---|
What | Depression and anxiety | Depression instruments / coded results |
When | Initial prenatal, later pregnancy, postpartum | PND-E in pregnancy; PDS-E postpartum (often 7-84 days) |
After positive | Diagnosis, treatment, follow-up systems | Follow-up within 30 days |
Postpartum visit | Early check-in + comprehensive visit by ~12 weeks | PPC visit 7-84 days |
Where PA plan programs break
Between-visit desert, mood crashes weeks after discharge with no owner until the next appointment.
Screen without closed-loop follow-up, positive EPDS in a portal queue fails the 30-day rate.
Data that never becomes ECDS, paper screens without LOINC.
Postpartum visit no-shows, logistics, not only clinical intent.
Fragmented BH access, a 6-week waitlist is not 30-day follow-up.
SDOH, housing/food/safety drive missed visits; link resources (SDOH finder).
Operating model: one perinatal quality system
Window | Action |
|---|---|
Pregnancy | Standardized depression screen(s); instrument + score electronic with LOINC path |
7-84 days postpartum | PPC postpartum visit and PDS-E screen in the same sprint |
0-30 days after positive | Qualifying follow-up encounter (visit, BH, CM with assessment, meds as appropriate) |
Electronic-first screening; avoid “screened in chat, never charted.”
Same-day clinical owner for positives, 30 days is the outer HEDIS bound, not the goal.
Chase postpartum visits as care, not robocall compliance.
Keep the OB as medical home with closed-loop summaries.
Verify in claims and clinical data, not vendor PDFs alone.
How Phia fits
Phia Health is a licensed Pennsylvania perinatal medical group. Continuous screening between visits; same-day licensed response after elevated scores; support for postpartum visit completion; claims-verifiable encounters; summaries back to the referring OB; in-network orientation with major PA plans and Medicaid.
Scale signals: 1,264+ active PA patients, 72 referring practices, 22 counties; internal markers include 94% screening completion, 23% reduction in avoidable ED visits, 87% care gaps closed.
Plans: Partners – payors and providers · UHC Community Plan: coverage path · OB tools: screening scales · Talk to us: request info
90-day checklist
Days 1-30: Baseline PPC and PND-E/PDS-E by product/region; map LOINC-capable vs paper screens; list upcoming deliveries without a scheduled postpartum visit.
Days 31-60: Same-day escalation for positive screens; embed standardized instruments in high-volume OB groups; postpartum outreach at day 3-5 and day 14 if unscheduled.
Days 61-90: Audit charts for coded screen + 30-day follow-up; compare no-shows; lock internal reporting so voluntary ECDS measures are operationally mandatory.
FAQ
Does a positive screen without treatment help? Screening numerators count documented results. Missing 30-day follow-up after a positive hurts the follow-up rate. (NCQA PDS-E)
Is anxiety in HEDIS like depression? ACOG pushes both clinically; PND-E/PDS-E center on depression instruments. Build anxiety pathways anyway.
Why is PA “high” still a priority? ~24% Medicaid screening leads state tables and is far from universal capture. Commercial lags further.
How does 12-month postpartum coverage interact? Use the full year for treatment continuity; still complete PPC/PDS-E early windows (notably 7-84 days).
Conclusion
HEDIS perinatal performance for Pennsylvania plans is a systems problem: coded screens, 30-day follow-up, and postpartum visits inside tight windows, while members live most of the continuum between OB appointments. Pair measure literacy with a between-visit clinical partner that documents like a medical group. Talk to Phia · Partner model
Educational overview for quality and clinical leaders. Confirm current HEDIS specs with your certified measure vendor and NCQA for the active measurement year. Not legal, coding, or medical advice.